Virtual Patient Groups for Sarcoidosis Associated Fatigue
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- The Cleveland Clinic
- Study ID
- NCT07073963
- Status
- Recruiting
Conditions
- Anxiety
- Depression
- Fatigue
- Mental Health
- Sarcoidosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Virtual Mindfulness Based Stress Reduction Group — BEHAVIORALMindfulness Based Stress Reduction is an evidence-based, manualized 8-week group program designed to improve coping with chronic physical and psychological symptoms. MBSR emphasizes mindfulness meditation, body awareness, and gentle movement to cultivate nonjudgmental awareness of present-moment experiences and reduce stress reactivity. The intervention will be delivered in a virtual group setting.
- Virtual sarcoidosis support group — BEHAVIORALParticipants attend a once-monthly, virtual support group via secure video conferencing. Each session includes a brief didactic presentation on topics relevant to living with chronic illness (e.g., symptom management, coping strategies, navigating healthcare) followed by a facilitated group discussion. The discussion emphasizes peer support, shared experiences, and emotional processing in a safe, respectful environment. Groups are led by an experienced facilitator with experience in chronic illness care. No home practice is required.
Study Details
This research study is testing whether Mindfulness-Based Stress Reduction (MBSR) can help reduce fatigue in people with sarcoidosis. The study will also look at whether MBSR can improve symptoms of anxiety and depression. Participants will be placed into one of two groups: * One group will take part in an 8-week virtual MBSR program, attend weekly online sessions, keep a daily mindfulness journal, and complete surveys about fatigue, anxiety, and depression. * The other group will join a virtual support group once a month for 5 months and complete the same surveys. The goal is to see which approach is more helpful for improving fatigue and mental well-being in people with sarcoidosis.
Key Dates
- Start date
- Feb 26, 2026
- Status verified
- Feb 2026
- Primary completion
- Mar 1, 2028
- Completion
- Mar 1, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 8 week Virtual Mindfulness Based Stress Reduction GroupThis group will meet with a certified Mindfulness Based Stress Reduction counselor one time a week to learn and practice mindfulness techniques as a means of addressing fatigue and mental health in sarcoidosis. This group will fill out diaries of their use of Mindfulness Based Stress Reduction techniques for the duration of the 8 week intervention and complete fatigue, depression, and anxiety surveys at time 0, 8 weeks, and 5 months.
- Active Comparator: Monthly Virtual Sarcoidosis Support groupThis group will be invited to join an existing virtual sarcoidosis support group. They will participate in the group for the 5 months of the trial. They will complete fatigue, depression, and anxiety surveys at time 0, 8 weeks, and 5 months.
Primary Outcome Measure
PROMIS Fatigue 8a [ Time Frame: From enrollment to the end of the study period at 5 months ]
Central Contacts
- Tiana Powell216-308-5111
- Logan J Harper, MD216-444-0013
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | Logan Harper, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Cleveland, OH
Related Studies
- Cardiac Sarcoidosis Randomized TrialPHASE3 · Recruiting · Ottawa Heart Institute Research Corporation · New Haven, Connecticut
- Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)PHASE4 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)PHASE4 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)PHASE4 · Recruiting · University of Cincinnati · Cincinnati, Ohio